After a large trial showed stronger protection, regulators are weighing whether Moderna’s mRNA vaccine could become a U.S.

The findings arrive after a swirl of regulatory uncertainty surrounding the trivalent (three-strain) vaccine, mRNA-1010.

An mRNA-based flu shot could make a huge difference in flu prevention, allowing scientists to pick a better strain match.

Those eager to discredit Pfizer's mRNA vaccine, which is safe and effective, exploited the cruise ship outbreak.

What Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 10.2% in the afternoon session after the company ...

Marjorie Taylor Greene and other conservative commentators have claimed that Moderna is developing a hantavirus mRNA vaccine.

Relative vaccine efficacy was 26.6 percent, which met the criteria for noninferiority, superiority, higher-level superiority.

A surprising backup system in the immune response to mRNA vaccines may hold the key to more effective cancer treatments.

A hantavirus vaccine is currently in preclinical development, but a publicly available shot is likely years away. Other ...

Bacteria fend off invading viruses with molecular scissors that slice up viral DNA—a system called CRISPR that's become ...